Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coya Therapeutics (COYA) Other Non Operating Income (2022 - 2025)

Coya Therapeutics (COYA) has disclosed Other Non Operating Income for 4 consecutive years, with -$903404.0 as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income rose 18.13% to -$903404.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $103368.0 through Dec 2025, up 2.46% year-over-year, with the annual reading at $103368.0 for FY2025, 2.46% up from the prior year.
  • Other Non Operating Income hit -$903404.0 in Q4 2025 for Coya Therapeutics, down from $317066.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $431089.0 in Q1 2024 to a low of -$1.1 million in Q4 2024.
  • Historically, Other Non Operating Income has averaged $56705.5 across 4 years, with a median of $161302.0 in 2023.
  • Biggest five-year swings in Other Non Operating Income: skyrocketed 5523.73% in 2023 and later plummeted 731.77% in 2024.
  • Year by year, Other Non Operating Income stood at $16330.0 in 2022, then skyrocketed by 969.64% to $174672.0 in 2023, then tumbled by 731.77% to -$1.1 million in 2024, then rose by 18.13% to -$903404.0 in 2025.
  • Business Quant data shows Other Non Operating Income for COYA at -$903404.0 in Q4 2025, $317066.0 in Q3 2025, and $319541.0 in Q2 2025.